Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
2,080.00    -62.00 (-2.89%)
Bid:
2,066.00
Ask:
2,070.00
Spread: 4.00 (0.194%)
Market Cap: £3.48b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Share buyback programme

24 Sep 2024 07:00

RNS Number : 3311F
Johnson Matthey PLC
24 September 2024
 

24th September 2024

 

Johnson Matthey Plc

Share buyback programme

 

On 3rd July 2024, Johnson Matthey Plc ("JM" or the "Company") announced its intention to conduct a share buyback programme to purchase ordinary shares of 110 49/53 pence each in the Company ("Ordinary Shares") for up to a maximum consideration of £250m (the "Buyback").

 

The first tranche of this Buyback (up to a maximum consideration of £125m) commenced on 3rd July 2024 and completed on 23rd September 2024, in accordance with its terms.

 

The Company announces that the second tranche of the Buyback of up to £125m will commence today and end no later than 24th January 2025. Purchases of the Company's ordinary shares will commence immediately.

 

The Company has entered into an irrevocable, non-discretionary agreement with Citigroup Global Markets Limited ("Citi") to manage the Programme, pursuant to which Citi will purchase Johnson Matthey Ordinary Shares (acting as principal) for subsequent repurchase by the Company. Citi will make trading decisions under the Programme independently of JM. Purchases may continue during any closed period to which the Company is subject.

 

The sole purpose of the Programme is to reduce the share capital of the Company. All shares repurchased under the Programme will be cancelled.

 

The maximum number of shares that may be repurchased under the Buyback is 18,393,997 shares, being the number of shares the Company is authorised to purchase pursuant to the authority granted by shareholders at the Company's 2024 Annual General Meeting (the "2024 AGM") and any subsequent authority.

Any purchase of Johnson Matthey ordinary shares in relation to this announcement will be effected within certain pre-set parameters and in accordance with Johnson Matthey's general authority to repurchase ordinary shares granted by its shareholders at the 2024 AGM, Chapter 12 of the Financial Conduct Authority's UK Listing Rules, the Market Abuse Regulation (EU) 596/2014 (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019); and the Commission Delegated Regulation (EU) No 2016/1052 (as in force in the UK and as amended by the FCA's Technical Standards (Market Abuse Regulation) (EU Exit) Instrument 2019). No repurchases will be made in respect of the Company's American Depositary Receipts.

 

 

ENDS

 

Enquiries: 

 

Martin Dunwoodie

Victoria Barlow

Director of Investor Relations and Treasury

Deputy Company Secretary

+44 20 7269 8241

+44 20 7269 8431

 

 

Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)

Registered in England & Wales number: 00033774Legal Entity Identifier number: 2138001AVBSD1HSC6Z10

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSEUESDELSEFU
Date   Source Headline
19th Sep 20194:21 pmRNSDirector/PDMR Shareholding
19th Sep 20197:00 amRNSJohnson Matthey Capital Markets Day
22nd Aug 20193:02 pmRNSDirector/PDMR Shareholding
22nd Aug 20192:55 pmRNSDirector/PDMR Shareholding
22nd Aug 20192:44 pmRNSDirector/PDMR Shareholding
22nd Aug 201911:53 amRNSDirector/PDMR Shareholding
12th Aug 20199:49 amRNSDirector/PDMR Shareholding
9th Aug 20199:45 amRNSDirector/PDMR Shareholding
9th Aug 20199:19 amRNSDirector/PDMR Shareholding
9th Aug 20199:06 amRNSDirector/PDMR Shareholding
8th Aug 20199:53 amRNSDirector/PDMR Shareholding
7th Aug 201912:42 pmRNSDirector/PDMR Shareholding
7th Aug 201912:33 pmRNSDirector/PDMR Shareholding
6th Aug 201911:06 amRNSDirector/PDMR Shareholding
6th Aug 201910:59 amRNSDirector/PDMR Shareholding
6th Aug 201910:54 amRNSDirector/PDMR Shareholding
2nd Aug 201911:40 amRNSDirector/PDMR Shareholding
2nd Aug 201911:33 amRNSDirector/PDMR Shareholding
19th Jul 20199:12 amRNSDirector/PDMR Shareholding
17th Jul 20193:24 pmRNSResult of AGM
17th Jul 20197:00 amRNSJohn Walker to retire; succeeded by Joan Braca
17th Jul 20197:00 amRNSAGM trading update
20th Jun 20192:05 pmRNSDirector/PDMR Shareholding
14th Jun 20197:00 amRNSAnnual Financial Report
30th May 20197:00 amRNSPreliminary results for year ended 31st March 2019
28th May 20197:00 amRNSDirectorate Changes
17th May 20192:03 pmRNSDirector/PDMR Shareholding
18th Apr 20193:41 pmRNSDirector/PDMR Shareholding
1st Apr 20197:00 amRNSDirectorate Change
28th Mar 20197:00 amRNSStrategic developments in eLNO commercialisation
21st Mar 20193:45 pmRNSDirector/PDMR Shareholding
21st Feb 20193:52 pmRNSDirector/PDMR Shareholding
7th Feb 20192:43 pmRNSDirector/PDMR Shareholding
7th Feb 20199:27 amRNSDirector/PDMR Shareholding
7th Feb 20199:25 amRNSDirector/PDMR Shareholding
7th Feb 20199:23 amRNSDirector/PDMR Shareholding
21st Jan 201910:43 amRNSDirector/PDMR Shareholding
17th Jan 20193:39 pmRNSDirector/PDMR Shareholding
21st Dec 20184:21 pmRNSDirector/PDMR Shareholding
11th Dec 201810:17 amRNSDirector/PDMR Shareholding
6th Dec 20185:22 pmRNSHolding(s) in Company
22nd Nov 201812:24 pmRNSDirector/PDMR Shareholding
21st Nov 20187:00 amRNSHalf-year Report
18th Oct 20184:20 pmRNSDirector/PDMR Shareholding
20th Sep 20184:42 pmRNSDirector/PDMR Shareholding
19th Sep 20183:57 pmRNSDirector/PDMR Shareholding
22nd Aug 201811:30 amRNSAlan Ferguson - New Directorship
16th Aug 20182:44 pmRNSDirector/PDMR Shareholding
16th Aug 20181:23 pmRNSDirector/PDMR Shareholding
15th Aug 201811:25 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.